Table. Baseline Patient Characteristics.
| Patient No./sex/age, y | Disease duration, mo | Manifestations | Affected nails | NAPSI | PPPASI | Previous treatments | |
|---|---|---|---|---|---|---|---|
| Osteoarticular | Dermatological | ||||||
| 1/F/30s | 27 | Anterior chest wall, sacroiliac joint, cervical vertebra | PPP on the palms and soles | Fingernails and toenails | 30 | 13.5 | TwHF, NSAIDs |
| 2/F/30s | 3 | Anterior chest wall, sacroiliac joint, lumbar vertebra, shoulder joint | PPP on the palms and soles, PV | Fingernails and toenails | 41 | 19.2 | NSAIDs, systemic corticosteroids |
| 3/F/40s | 17 | Anterior chest wall, ankle joint | PPP on the palms and soles | Fingernails and toenails | 48 | 12.8 | NSAIDs, adalimumab |
| 4/F/50s | 12 | Anterior chest wall, thoracic vertebra, shoulder joint, knee joint | PPP on the palms and soles | Fingernails and toenails | 40 | 8.1 | TwHF, MTX, NSAIDS, systemic corticosteroids |
| 5/F/30s | 24 | Anterior chest wall, knee joint, ankle joint | PPP on the palms and soles | Fingernails and toenails | 51 | 15.1 | MTX, IEF, TwHF, NSAIDs |
| 6/F/50s | 16 | Anterior chest wall, sacroiliac joint | PPP on the palms and soles, PV | Fingernails and toenails | 141 | 52.2 | Etanercept, NSAIDs |
| 7/F/50s | 12 | Anterior chest wall | PPP on the palms and soles, PV | Fingernails and toenails | 90 | 24.6 | MTX |
| 8/F/20s | 60 | Anterior chest wall, hip joint, metacarpophalangeal joints | PPP on the palms and soles, PV | Fingernails and toenails | 86 | 10.8 | Cyclosporin |
| 9/F/30s | 180 | Anterior chest wall, shoulder joint | PPP on the palms | Fingernails | 63 | 16.8 | MTX, SASP, THD, TwHF, NSAIDs, systemic corticosteroids |
| 10/F/20s | 6 | Anterior chest wall, sacroiliac joint | PPP on the palms and soles, PV | Fingernails and toenails | 53 | 26.8 | BPs, SASP, NSAIDs |
| 11/F/50s | 10 | Anterior chest wall, shoulder joint, knee joint | PPP on the palms and soles, PV | Fingernails and toenails | 34 | 9.2 | Systemic corticosteroids |
| 12/F/40s | 4 | Anterior chest wall, lumbar vertebra | PPP on the palms and soles | Fingernails and toenails | 37 | 15.8 | None |
| 13/F/10s | 1 | Anterior chest wall, cervical vertebra | PPP on the palms | Fingernails | 33 | 9.6 | None |
Abbreviations: BPs, bisphosphonates; IEF, leflunomide; MTX, methotrexate; NAPSI, nail psoriasis severity index; NSAIDs, nonsteroidal anti-inflammatory drugs; PPP, palmoplantar psoriasis; PPPASI, palmoplantar psoriasis area and severity index; PV, psoriasis vulgaris; SASP, salazosulfapyridine; THD, thalidomide; TwHF, tripterygium wilfordii Hook F.